文献速递血栓与止血

血小板颗粒疾病基因组学时代的黎明:提升认识、诊断与管理

Dawning of the age of genomics for platelet granule disorders: improving insight, diagnosis and management.
PubMed 文献 · Br J Haematol · 2016-12-16

遗传性血小板颗粒疾病临床异质性强,多数患者未完成完整诊断检查,患病率被低估。高通量测序(HTS)作为常规临床诊断检测可平行筛查全部80个已知出血、血栓和血小板基因,提高遗传诊断并加深对疾病病理生物学和临床病程的理解。全基因组和表观基因组测序时代需要整合多源大数据以寻找颗粒疾病的新基因。

要点

  • HTS可平行筛查全部80个已知出血、血栓和血小板基因。
  • 遗传诊断可辅助管理、家系筛查、计划生育和预测临床进展。
  • 颗粒生物发生调控和遗传病因的认识仍在进展中。

核心结论

  • 高通量测序作为常规临床诊断检测可提高遗传性血小板颗粒疾病的遗传诊断率并加深对疾病病理生物学和临床病程的理解。
  • 全基因组和表观基因组测序时代需要新策略整合多源大数据以寻找颗粒疾病的隐匿新基因。

研究设计与样本

  • 综述,讨论高通量测序在遗传性血小板颗粒疾病诊断和管理中的应用前景。

主要发现

  • 遗传性血小板颗粒疾病临床异质性强,多数患者未完成完整诊断检查,患病率被低估。
  • 缺乏遗传诊断限制了个体化管理、家系筛查、计划生育、预测临床进展和及时检测骨髓纤维化、肺纤维化及恶性肿瘤等严重结局的能力。
  • 高通量测序诊断检测现已可用、可负担,并可平行筛查全部80个已知出血、血栓和血小板基因的变异。
  • 遗传诊断和变异注释的增加正在提高对遗传性血小板疾病病理生物学和临床病程的理解。
  • 近期全基因组关联研究和基因组测序项目产生的基因组学发现显著增进了对血小板颗粒疾病遗传病因和颗粒生物发生调控的认识。

关键数值与推荐

  • 高通量测序可平行筛查全部80个已知出血、血栓和血小板基因的变异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Inherited disorders of platelet granules are clinically heterogeneous and their prevalence is underestimated because most patients do not undergo a complete diagnostic work-up. The lack of a genetic diagnosis limits the ability to tailor management, screen family members, aid with family planning, predict clinical progression and detect serious consequences, such as myelofibrosis, lung fibrosis and malignancy, in a timely manner. This is set to change with the introduction of high throughput sequencing (HTS) as a routine clinical diagnostic test. HTS diagnostic tests are now available, affordable and allow parallel screening of DNA samples for variants in all of the 80 known bleeding, thrombotic and platelet genes. Increased genetic diagnosis and curation of variants is, in turn, improving our understanding of the pathobiology and clinical course of inherited platelet disorders. Our understanding of the genetic causes of platelet granule disorders and the regulation of granule biogenesis is a work in progress and has been significantly enhanced by recent genomic discoveries from high-powered genome-wide association studies and genome sequencing projects. In the era of whole genome and epigenome sequencing, new strategies are required to integrate multiple sources of big data in the search for elusive, novel genes underlying granule disorders.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Bariana TK, Ouwehand WH, Guerrero JA, et al. Dawning of the age of genomics for platelet granule disorders: improving insight, diagnosis and management. Br J Haematol. 2016. PMID: 27984638. doi:10.1111/bjh.14471

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。